The global vaccines market was valued at USD 90.28 billion in 2023 and is expected to grow from USD 87.57 billion in 2024 to USD 159.28 billion by 2032, reflecting a CAGR of 7.8% during the forecast period. In North America, the vaccines market is projected to expand from USD 37.57 billion in 2023 to USD 38.75 billion in 2024.

The vaccines market plays a critical role in global public health by preventing the spread of infectious diseases and reducing disease burden across populations. Driven by rising awareness, government immunization initiatives, and advancements in biotechnology, the vaccines market has seen rapid innovation and expansion. The development of novel vaccine platforms such as mRNA, DNA-based, and recombinant vaccines has significantly improved efficacy and response times during outbreaks. Growing demand for both pediatric and adult immunization, coupled with increasing investment in research and production infrastructure, is contributing to the market’s continued growth. Despite challenges such as vaccine hesitancy and distribution hurdles, the vaccines market remains a cornerstone of preventive healthcare worldwide.

Continue reading for more details:

**https://www.fortunebusinessinsights.com/industry-reports/vaccines-market-101769**

Market Segmentation

• By Type: Includes inactivated vaccines, live attenuated vaccines, subunit/conjugate vaccines, mRNA vaccines, and toxoid vaccines.
• By Disease Indication: Covers influenza, HPV, COVID-19, hepatitis, pneumococcal, meningococcal, DTP, and others.
• By Age Group: Segments include pediatric, adolescent, adult, and geriatric populations, all contributing to the vaccines market.
• By Route of Administration: Intramuscular, subcutaneous, oral, and intradermal routes play critical roles in the vaccines market.
• By End User: Includes hospitals, clinics, vaccination centers, and public health agencies driving demand in the vaccines market.

List Of Key Companies Profiled in Vaccines Market:

• GlaxoSmithKline plc. (U.K.)
• Sanofi (France)
• Pfizer Inc. (U.S.)
• Merck & Co., Inc. (U.S.)
• Novartis AG (Switzerland)
• Emergent BioSolutions, Inc. (U.S.)
• CSL Limited (Australia)
• Inovio Pharmaceuticals, Inc. (U.S.)